Skip to main content
. Author manuscript; available in PMC: 2022 Apr 5.
Published in final edited form as: Eur J Med Chem. 2021 Feb 3;215:113252. doi: 10.1016/j.ejmech.2021.113252

Figure 3:

Figure 3:

Intracellular flow cytometry analysis of CXCL8 in U2OS/NOD2 cells treated with L18-MDP (200 ng/mL, 4 h). Percentage of CXCL8 positive cells in the presence of inhibitors 16, 17, 31 and 33 at various concentrations versus DMSO control shown. Data points are the average of three experiments.